Drug Firms to Now Face Bans for Fake Claims, as Govt to Tweak Rules

FDA to speed up approvals of generic biologic medicines as Trump targets high drug costs

It's the Trump administration's latest move to rein in high prescription drug costs in the U.S., and could be a blow to pharmaceutical companies.

Kennedy, Makary, and Oz to Announce Major Actions to Lower Drug Costs

Health Secretary RFK Jr., FDA Commissioner Marty Makary, and CMS Administrator Mehmet Oz announce major actions to lower drug costs on Oct. 29.

Drug firms to now face bans for fake claims, as govt to tweak rules

The tightening of the rules assumes significance for India, the world’s largest supplier of generic medicines, exporting over 20% of global volumes to more than 200 countries, including the US and EU.

FDA plans to speed approvals of biosimilars

FDA to speed up frequent drugs authorizations as Trump targets drugs costs

The Food and Drug Administration on Wednesday claimed it can actually take steps to speed up the process of making frequent variations of sophisticated natural medicines, in a proposal to boost less expensive rivals for expensive drugs and diminished drugs costs forAmericans It’s the Trump administration’s most present relocate to examine excessive prescription drugs costs within the united state, the place drug prices are two-to-three instances…

Trump’s Prescription Drug Policy: Rhetoric vs. True Reform

In his first nine months in office, President Donald Trump has issued a flurry of executive actions in the name of lowering prescription drug costs in the United States. Yet, Americans continue to pay three times as much as our peers for prescription drugs. Why is there a gap between the president’s rhetoric and realized reform?  Almost all Americans agree that prescription costs are too high, and the president is rightly focusing on this issue …